CA2308475A1 - Devices for forming and/or maintaining connections between adjacent anatomical conduits - Google Patents

Devices for forming and/or maintaining connections between adjacent anatomical conduits Download PDF

Info

Publication number
CA2308475A1
CA2308475A1 CA002308475A CA2308475A CA2308475A1 CA 2308475 A1 CA2308475 A1 CA 2308475A1 CA 002308475 A CA002308475 A CA 002308475A CA 2308475 A CA2308475 A CA 2308475A CA 2308475 A1 CA2308475 A1 CA 2308475A1
Authority
CA
Canada
Prior art keywords
members
strut
annular
strut members
annular members
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002308475A
Other languages
French (fr)
Inventor
Steven Kim
J. Christopher Flaherty
Jason Brian Whitt
Theodore C. Lamson
Joshua Makower
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transvascular Inc
Original Assignee
Transvascular, Inc.
Steven Kim
J. Christopher Flaherty
Jason Brian Whitt
Theodore C. Lamson
Joshua Makower
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transvascular, Inc., Steven Kim, J. Christopher Flaherty, Jason Brian Whitt, Theodore C. Lamson, Joshua Makower filed Critical Transvascular, Inc.
Publication of CA2308475A1 publication Critical patent/CA2308475A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12027Type of occlusion
    • A61B17/1204Type of occlusion temporary occlusion
    • A61B17/12045Type of occlusion temporary occlusion double occlusion, e.g. during anastomosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12136Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3417Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/064Blood vessels with special features to facilitate anastomotic coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2493Transmyocardial revascularisation [TMR] devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B17/0643Surgical staples, i.e. penetrating the tissue with separate closing member, e.g. for interlocking with staple
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1477Needle-like probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491Surgical glue applicators
    • A61B2017/00504Tissue welding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1107Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis for blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/11Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
    • A61B2017/1139Side-to-side connections, e.g. shunt or X-connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/12127Double occlusion, e.g. for creating blood-free anastomosis site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/30Surgical pincettes without pivotal connections
    • A61B2017/306Surgical pincettes without pivotal connections holding by means of suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B2017/347Locking means, e.g. for locking instrument in cannula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00392Transmyocardial revascularisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1425Needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/40Apparatus fixed or close to patients specially adapted for providing an aseptic surgical environment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30079Properties of materials and coating materials magnetic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/825Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having longitudinal struts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91575Adjacent bands being connected to each other connected peak to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91591Locking connectors, e.g. using male-female connections
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/009Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof magnetic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0048Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A61M25/0075Valve means
    • A61M2025/0076Unidirectional valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0082Catheter tip comprising a tool
    • A61M25/0084Catheter tip comprising a tool being one or more injection needles
    • A61M2025/0089Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
    • A61M2025/009Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip the needle having a bent tip, i.e. the needle distal tip is angled in relation to the longitudinal axis of the catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1052Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector

Abstract

Implantable connector devices (10) which are useable to maintain fluidic connection between or approximation of, openings formed in adjacent natural or prosthetic anatomical conduits (or adjacent openings formed in a single anatomical conduit). These connector devices (10) generally comprise a plurality of radially expandable annular members (12a-12c) having one or more elongate strut members (14) extending therebetween. Initially, the device (10) is mountable on or within a delivery catheter while in a radially compact configuration. After the delivery catheter has been inserted into the body, the device is caused to transition to a radially expanded configuration whereby it becomes implanted within the body so as to maintain the desired fluidic connection between, or the desired approximation of, the anatomical conduit(s).

Description

DEVICES FOR FORMING AND/OR MAINTAINING CONNECTIONS BETWEEN
ADJACENT ANATOMICAL CONDUITS
Related Applications This application is a continuation-in-part of co-pending PCT International Application No. PCT/LTS97/01468 filed on January 31, 1997, and of co-pending United States Patent Application Serial Nos. 08/730,327 filed on October 11, 1996 and 08/730, 496 filed on October 11, 1996. The entire disclosure of each such related application is expressly incorporated herein by reference.
Field of the Invention The present invention relates generally to medical devices and methods, and more particularly to devices and methods for forniing connections or facilitating flow between openings formed in adjacently situated anatomical conduits.
Background of tire Invention In modern medical practice, it is sometimes desirable to form flow-through connections (e.g., passageways or flow channels) between adjacent anatomical conduits (natural or prosthetic), or between adjacent segments of a single anatomical conduit. The types of natural and prosthetic anatomical and conduits) which may be linked by such flow-through connections include; blood vessels, vas deferens, fallopian tubes, intestines, lymphatic ducts, grafts, etc.
In particular, United States Patent Application Serial Nos. 08/730,327 and 08/730,496 have described certain methods and devices for performing transluminal, catheter-based, bypass procedures wherein flow-thmugh connections are formed between two adjacently situated anatomical conduits (e.g., blood vessels) to bypass a diseased, injured or obstructed segment of one of those anatomical conduits, using a segment of the adjacent conduit as the bypass loop. These procedures include catheter based, transluminal, in situ coronary vein bypass procedures wherein at least one primary flow-through connection (i.e., bloodflow passageways) is formed between an obstructed coronary artery and an adjacent coronary vein, such that blood will flow from the obstructed artery into the adjacent coronary vein. The arterial blood which has flowed into the coronary vein may then be allowed to retroperfuse the ischemic myocardium by retrograde flow through the coronary vein. Or, alternatively, one or more secondary flow-through connections may be formed between the coronary vein and the obstructed artery at sites) downstream of the obstruction (or some other coronary artery), thereby allowing the arterial blood which had flowed into the coronary vein to reenter the obstructed artery (or some other coronary artery), after having bypassed the arterial obstruction.
Also, International Patent Publication No. WO 97/27897 describes certain thoracoscopic or minimally invasive methods for by-passing an obstructs coronary artery by maneuvering, into juxtaposition with the obstructed artery, a tubular graft. Openings are formed in the juxtapositioned graft and in the adjacent artery, at sites upstream and downstream of the obstruction. The graft is then connected to the artery such that the openings in the graft are positioned in alignment with, and in fluidic connection with, the openings in the artery. Bload may then flow through the flow-through connections between the tube graft and the artery, thereby bypassing an obstructed region of the artery.
Additionally, United States Patent No. 3,042,021 (Read), entitled Bypass Type Insert Plug For Body Passageway, describes a procedure wherein an apparatus is used to connect or facilitate flow between openings formed in adjacent anatomical passageways (e.g., genitourinary ducts), which are situated in side-to-side juxtaposition.
Also, United States Patent No. 5, 443, 497 (Venbrux), entitled Purcutaneous Prosthetic By-Pass Craft and Method of Use, describes a device for bypassing an occluded lumen or for coupling two lumens, and related methods for installing such devices) within the body.
At least some of the previously described procedures for forming flow-through connections (e.g., passageways or flow channels) between adjacent anatomical conduits may be accomplished by a transluminal, catheter-based approach which avoids the need for open surgical exposure and dissection of the involved anatomical passageways. Such transluminal procedures generally require the passage of a flexible cannula or catheter through the lumen of one of the involved body passageways, deploying or actuating a tissue penetration element from the catheter, through the wall
2
3 PCT/US98/23916 of the passageway in which the catheter is positioned, and into the adjacent passageway to which the side to side connection is to be made. In at least some of these transluminal, catheter-based procedures, it is additionally desirable to install a connector apparatus to maintain the desired alignment of the flow-through openings in the adjacent anatomical conduits, and/or to prevent the S leakage of body fluid into the surrounding tissues or spaces. Some connector apparatus of this type have previously been described in United States Patent Application Serial Nos.
08/730,327 and 08/730,496 as well as International Patent Publication No. WO 97/27898 entitled "Methods and Apparatus for Connecting Openings Formed in Adjacent Blood Vessels or Other Anatomical Conduits". However, none of these previously described methods or apparatus appear to be of optimal design for all clinical applications.
Accordingly, there exists a need in the art for the design and development of new apparatus for connecting or maintaining alignment of flow-through openings formed in adjacent blood vessels or other anatomical conduits. It is further desirable that such connector apparatus be implantable by a transluminal, catheter-based technique to avoid the need for open surgical exposure of the affected anatomical conduits.
Suramary of the Invention The present invention includes devices and methods for connecting, or facilitating flow between, adjacently situated anatomical or prosthetic conduits) (e.g., openings in separate anatomical conduits or two openings at different locations in the same anatomical conduit). The connector devices of the present invention include certain "two-annular-member" embodiments and "three-annular-member" embodiments, as described more fully herebelow.
In accordance with the invention, there is provided a two-annular-member connector device which is implantable within the body of a mammal to facilitate flow between (i.e, to maintain alignment and/or connection between) a first opening fonmed in an anatomical conduit (e.g., a first blood vessel), and a second opening formed in an anatomical conduit (e.g., an opening formed in a second blood vessel or a second opening formed in the first blood vessel).
This two-annular-member connector device generally comprises (a) at least one proximal radially expandable annular member, (b) at least one distal radial expandable annular member, (c) at least one strut member connected to and extending between the proximal and distal annular members. Prior to implantation in the body, this two-annular-member connector device is disposed in a collapsed disposition with its proximal and distal annular members in their radially collapsed configurations and its strut members) in a pre-expansion configuration. In this collapsed disposition, the connector device is sufficiently compact to be mounted upon or within a delivery catheter which is transluminally advancable to site of intended implantation. After the delivery catheter has been transluminally advanced to the site of intended implantation, the connector device is released or separated from the delivery catheter, its proximal and distal annular members are expanded to their radially expanded configurations, and its strut members) caused or permitted to assume a post-expansion (i.e., curved) configuration. In this manner the connector device may be implanted with its proximal annular members) at a first location in an anatomical or prosthetic conduit (e.g., a first blood vessel), its distal annular members) at a second location in an anatomical or prosthetic conduit (e.g., a second blood vessel or a second location within the first blood vessel), and its strut members) extending therebetween. When so implanted, the two-annular-member connector device may serve to maintain the patency, alignment and/or approximation of the first and second openings--and of any interstitial tunnel, passageway or bypass conduit created or disposed between such openings.
Further in accordance with the invention, there is provided a three-annular-member connector device which is implantable within the body of a mammal to facilitate flow between (i.e, to maintain alignment and/or connection between) a first opening formed in an anatomical conduit (e.g., a first blood vessel), and a second opening formed in an anatomical conduit (e.g., an opening formed in a second blood vessel or a second opening formed in the first blood vessel).
This three-annular-member connector device generally comprises (a) at least one proximal radially expandable annular member, (b) at least one distal radially expandable annular member, (c) at least one medial radially expandable annular member, (d) at least one first strut member connected to and extending between the proximal and medial annular members, and (e) at least one second strut member connected to and extending between the medial and distal annular members. This device is initially mountable upon or in a deliver catheter while in a collapsed disposition wherein the proximal, distal and medial annular members are in radially compact configurations and the strut members are in "pre-expansion" configurations. Thereafter the device is transitioned to an implantation disposition
4 wherein the proximal, distal and medial annular members are in their radially expanded configurations and the strut members) are in their "post-expansion" (e.g., curved) configurations.
This results in the connector device being implanted with its proximal annular members) at a first location in an anatomical or prosthetic conduit (e.g., within a first blood vessel), its distal annular members) at a second location in an anatomical or prosthetic conduit (e.g., within a second blood vessel or a second location within the first blood vessel), and its medial annular members) located within or between the first and second openings of the anatomical or prosthetic conduit(s). When so implanted, the three-annular-member connector device may serve to maintain the patency, alignment and/or approximation of the first and second openings--and of any interstitial tunnel, I 0 passageway or bypass conduit created or disposed between such openings.
Still further in accordance with the invention, in either the two-annular-member or three-annular-member connector devices, the actual number of annular members present (i.e., in excess of two (2) or three (3)) may be determined by functional considerations, such as the amount of scaffolding of support required to maintain the desired patency and approximation of the flow channels, and/or the specific position at which the device is to be implanted within the body.
Still further in accordance with the invention, any embodiment of the connector device of the present invention may be fully or partially covered by a pliable covering (e.g., woven polyester, expanded polytetrafluoroethylene (ePTFE), polyurethane, etc.) to channel, direct, block, or otherwise control the flow of body fluid and/or to improve the biological compatibility of the connector device.
Additionally or alternatively, such covering may be formed of material which will promote or prevent proliferation of the adjacent tissue. In some applications, the covering may be formed of material wick will biodegrade or become absorbed after it has served its intended purpose. Flow through holes or openings may be formed at selected locations in such pliable covering to direct or permit the desired flow of body fluid through the device. Such flow-through holes or openings may be formed in the covering prior to implantation of the connector device, or may be formed in situ following implantation of the connector device.
Still further in accordance with the present invention, the annular members and/or strut members) of the connector devices may be formed of a resilient material which is initially compressible and constrainable such that the annular members are in their radially collapsed states
5 WO 99/5273 ~ PCTNS98/23916 and the strut members) are in their pre-expansion configurations but which, when unconstrained, will self expand to a configuration wherein the annular members are expanded and the strut members) are in their post-expansion configurations. Alternatively, the annular members and/or strut members) of the connector devices may be formed of a malleable (e.g., plastically deformable) material which is initially formed such that the annular members are in their radially collapsed states and the strut members) are in their pre-expansion configurations but which, when outward radial pressure is exerted thereagainst, will plastically deform to a configuration wherein the annular members are expanded and the strut members) are in their post-expansion configurations..
Still fi~rther in accordance with the invention, the connector devices may be implanted in various different orientations or arrangements and/or my be purposely formed or deformed in a manner which will exert a traction force upon the surrounding tissue. Such traction force may be utilized to cause sloping or curvature of the openings formed in the first and second anatomical conduits and/or any surrounding tissue, to promote non-turbulent, laminar flow of blood or other body fluid between the anatomical conduits. In this regard, the invention includes methods (described in detail herebelow), for placing the connector devices in opposing orientations so as to cause two (2) adjacent interstitial passageways to angle or slope toward one another to promote non-turbulent flow therethrough.
Further aspects and advantages of the present invention will be apparent to those skilled in the art, after reading and understanding the detailed description of preferred embodiments set forth herebelow, and after viewing the accompanying drawings.
Brief Description of the Drawings Figure 1 a is a schematic showing of adjacent anatomical conduits which have an interstitial passageway formed therebetween and a two-annular member connector device of the present invention disposed therewithin.
Figure lb is a schematic showing of adjacent anatomical conduits which have an interstitial passageway formed therebetween and a three-annular member connector device of the present invention disposed therewithin.
Figure lc is a perspective view of a two-annular-member connector device of the present
6 invention in a fully assembled, operative configuration.
Figure ld is a perspective view of a three-annular-member connector device of the present invention in a fully assembled, operative configuration.
Figure 2 is a plan view of a preferred two-annular member connector device of the present invention disposed in a flattened, pre-assembly configuration.
Figure 2a is an enlarged perspective view of segment 2a of Figure 2, showing an alternative hinged connection formed between the strut members and the annular member componnet(s) of the connector device.
Figure 2b is an enlarged perspective view of segment 2b of Figure 2, showing optional interconnecting members of a first type formed between adjacent strut members of the connector device.
Figure 2c is an enlarged perspective view of segment 2c of Figure 2, showing optional interconnecting members of a second type formed between adjacent strut members of the connector device.
1 S Figure 2d is an enlarged perspective view of segment 2d of Figure 2, showing optional curved regions formed in the strut members of the connector device to provide for adjustability in length of the device.
Figure 3 is a plan view of a preferred three-annular member connector device of the present invention, disposed in a flattened, pre-assembly configuration.
Figure 4a is a side elevational view of a delivery catheter marker of the present invention disposed in a first rotational orientation, accompanied therebeneath by a schematic showing of a connector device of the present invention in a corresponding first rotational orientation.
Figure 4b is a side elevational view of a delivery catheter marker of the present invention disposed in a first rotational orientation, accompanied therebeneath by a schematic showing of a 2S connector device of the present invention in a corresponding third rotational orientation.
Figure 4c is a side elevational view of a delivery catheter marker of the present invention disposed in a third rotational orientation,. accompanied therebeneath by a schematic showing of a connector device of the present invention in a corresponding third rotational orientation.
Figures Sa-Sc are step-wise, schematic showings of a delivery catheter which incorporates
7 a marker of the present invention, being used to deliver a connector device of the present invention to form a connection between adjacently situated anatomical conduits in which openings have been formed.
Figure 6a is a perspective view of a connector device of the present invention having an optional covering formed thereon, with flow-through openings formed at selected locations in the covering.
Figure 6b is a perspective view of a connector device of the present invention having an option partial covering formed thereon, such covering being substantially confined to the mid-portion of the device..
Figures 7a-7e are step-wise schematic showings of a method for in situ formation of the flow-through openings in the covered connector device of Figure 6, after the connector device has been implanted within adjacent anatomical conduits.
Figures 8a-8e are step-wise schematic showings of the performance of one transluminal procedure to bypass of an arterial obstruction using a segment of an adjacent vein as an in situ bypass conduit, and wherein the connector devices of the present invention are implanted in opposing orientations to facilitate smooth, laminar blood flow through the vein segment.
Figures 9a-9e are step-wise schematic showings of the performance of another transluminal procedure to bypass of an arterial obstruction using a segment of an adjacent vein as an in situ bypass conduit, and wherein the connector devices of the present invention are implanted in opposing orientations to facilitate smooth, laminar blood flow through the vein segment.
Figures l0a-1 Oj are step-wise schematic showings of the performance of another transluminal procedure to bypass of an arterial obstruction using a segment of an adjacent vein as an in situ bypass conduit, and wherein the connector devices of the present invention are implanted in opposing orientations to facilitate smooth, laminar blood flow through the vein segment.
Figures 11 a-11 a are step-wise schematic showings of the performance of another transluminal procedure to bypass of an arterial obstruction using a segment of an adjacent vein as an in situ bypass conduit, and wherein a single connector device of the present invention, which incorporates a partial covering thereon, is implanted such that a) its proximal and distal annular members are disposed in a single artery at locations upstream and downstream of an obstruction, b)
8 its strut members extend through a segment of an adjacent vein, and c) its covering serves to block to outflow of blood into venous side branches which emanate from the segment of vein.
Figure 12 shows the manner in which body fluid (e.g., blood) may flow between the strut members of certain embodiments of the connector members of the present invention.
Figure 13 is a perspective view of a connector device of the present invention implanted within a bifurcated anatomical conduit.
Figure 14 is a schematic, elevational view of adjacent anatomical conduits having a single passageway formed therebetween and a three-annular-member connector device (which includes more than one proximal annular member and more than one distal annular member) implanted within the passageway such that it extends into both anatomical conduits.
Figure 15 is a schematic, elevational view of adjacent anatomical conduits having two interstitial passageways formed therebetween and the connector device of Figure 14 implanted therein such that one end of the device extends into one of the anatomical conduits and the other end of the device is positioned within one of the interstitial passageways.
Figure 16 is a schematic, elevational view of adjacent anatomical conduits having two interstitial passageways formed therebetween and two-annular-member connector device implanted therein such that one end of the device extends into one of the anatomical conduits and the other end of the device is positioned within one of the interstitial passageways.
Figure 17 is a schematic, elevational view of adjacent anatomical conduits having two interstitial passageways formed therebetween and the two-annular-member connector device of Figure 16 implanted therewithin such that one end of the device terminates in one of the interstitial passageways and the other end of the device terminates within the other interstitial passageway.
Figure 18 is a schematic showing of the anatomical "Brouck-Moscheau " having i) a first interstitial passageway formed between the Circumflex coronary artery and the Great Cardiac Vein, ii) a second interstitial passageway fonned between the Anterior Interventricular Vein and the Left Anterior Decending coronary artery, and iii) connector devices of the present invention disposed within those first and second interstitial passageways to facilitate coronary revascularization.
9 WO 99/25273 ~ PCT/US98/23916 Detailed Description of the Preferred Embodiments The following detailed description and the accompanying drawings are provided for purposes of describing and illustrating presently preferred embodiments and/or examples of the invention only, and are not intended to limit the scope of the invention in any way.
A. Structure and Function of the Two-Annular Member and Three-Annular Member Connector Devices Figure 1 a shows, in schematic fashion, a two-annular member connector device
10 of the present invention operatively implanted so as to maintain connection between a first opening OP, formed in the wall of a first anatomical conduit AC, and a second opening OPZ
formed in the adjacent wall of a second anatomical conduit ACz. This two-annular member connector device 10 generally comprises proximal and distal radially expandable annular members 12a, 12b having a plurality of strut members 14 extending therebetween. As shown, the proximal annular member 12a may be positioned within the lumen of the first anatomical conduit AC, so as to frictionally engage the surrounding wall of that anatomical conduit AC, , the distal annular member 12b is positioned within the lumen of the second anatomical conduit ACZ so as to frictionally engage the surrounding wall of that anatomical conduit ACz , and the strut members 14 extend through the respective first and second openings OP, , OPZ . In this manner, the connector device 10 forms a connection between the first and second anatomical conduits AC, , ACZ and maintains the first and second openings OP, , OP, in alignment with one another such that body fluid (e.g., blood) may flow therethrough.
Figure lb shows, in schematic fashion, a three-annular member connector device 10' of the present invention operatively implanted so as to maintain connection between a first opening OP, formed in the wall of a first anatomical conduit AC, , and a second opening OPz formed in the adjacent wall of a second anatomical conduit ACZ, This three-annular member connector device 10' generally comprises proximal, distal and medial radially expandabe annular members 12a,12b, 12c.
A plurality of first strut members 14a extend between the proximal annular member 12a and the medial annular member 12c. A plurality of second strut members 14b extend between the medial annular member 12c and the distal annular member 12b. As shown, the proximal annular member 12a may positioned within the lumen of the first anatomical conduit AC, so as to frictionally engage WO 99!25273 PCTNS98I23916 the surrounding wall of that anatomical conduit AC, , the distal annular member 12b is positioned within the lumen of the second anatomical conduit ACi so as to frictionally engage the surrounding wall of that anatomical conduit ACZ , and the medial annular member 12c is positioned within the passageways or openings OP, , OP2 formed in the walls of the adjacent anatomical conduits AC, , ACZ and/or within any intervening tissue (e.g., connective tissue, muscle, etc.) which may reside between the first and second anatomical conduits AC, , ACz . In this manner, the three-annular member connector device 10' forms a connection between the first and second anatomical conduits AC, , ACZ and maintains the first and second openings OP, , OPZ in alignment with one another such that body fluid (e.g., blood) may flow therethrough. Additionally, in this three-annular-member embodiment, the medial annular member 12c provides additional scaffolding or support for tissue which surrounds the first and second openings OP, , OPZ to maintain patency of the flow-through passageway and/or may act as a bulkhead or barrier to deter or prevent body fluid (e.g., blood) from infiltrating or leaking into the region between the adjacent anatomical conduits AC, , ACZ .
The two-annular-member connector device 10 or the three-annular-member connector device 10' may be formed at least partially of resilient material which is preformed and biased to a curvilinear shape (e.g., a serpentine shape having a first curve in one direction and a second curve in another direction) as shown in Figures la and lb. Alternatively such devices 10, 10' may be of a flexible or hinged construction which will allow them to assume the desired curved (e.g., serpentine) configuration when implanted. Also, as shown in Figure 11 a and described more fully herebelow, the two-annular-member connector device 10 may be preformed to a multicurvate shape wherein the struts 14 are preformed or formable to a generally "U" shaped configuration such that the proximal and distal annular members 12a, 12b may reside at spaced apart locations in the first anatomical conduit AC,, and the strut members 14 extend through the first and second passageways or openings OP,, OP2, and through the adjacent segment of the second anatomical conduit (e.g., a vein which lies adjacent to an obstructed artery) which is being used as an in situ bypass conduit.
Figure 1 c is a more detailed showing of the preferred two-annular-member connector device 10 of Figure 1 a. In this preferred embodiment, the proximal and distal annular members 12a, 12b comprise alternating (e.g., zig-zag or sinusoidal) elongate members 16 which, when in their radially expanded configuration, have linear portions 18 and apices 20 which define a generally cylindrical
11 annular shape. Four (4) strut members 14 are included in this embodiment. The opposite ends of each strut member 14 are connected to the inboard apices 20 of the alternating elongate members 16 which make up each annular member 12a, 12b, as shown. In this manner, the strut members 14 combine with the alternating elongate members 16 to define a longitudinal flow-through space FS
through which a biological fluid (e.g., blood) may flow. A longitudinal axis LA is projectable through this device, when in its radially expanded implantation configuration, as shown in Figure lc.
Figure 1 d is a more detailed showing of the preferred three-annular-member connector device of Figure lb. In this preferred embodiment, the proximal, distal and medial annular members 10 12a, 12b, 12c comprise alternating (e.g., zig-zag or sinusoidal) elongate members 16 which, when in their radially expanded configuration, have linear portions 18 and apices 20 which define a generally cylindrical annular shape. Four (4) strut members 14 are included in this embodiment.
The opposite ends of the strut members 14a, 14b are connected to the adjacent apices 20 of the alternating elongate members 16 which make up each annular member 12a, l2b,l2c, as shown. In this manner, the strut members 14a, 14b combine with the alternating elongate members 16 to define a longitudinal flow-through space FS through which a biological fluid (e.g., blood) may flow. A
longitudinal axis LA is projectable through this device, when in its radially expanded implantation configuration, as shown in Figure 1 d. It should also be appreciated that by varying the width of the strut members I4, the amount of radial force imparted by the strut members 14 against the tissue can be varied in accordance with the amount of force required to maintain patency of the flowpath in the subject anatomy.
The connector devices 10,10' may be fabricated in any suitable way, of any suitable material.
For example, the connector devices 10, 10' may be cut (e.g., laser cut) from a solid, cylindrical tube, or they may be fabricated from wire or other suitable strand-like material.
Figures 2 and 3 show flattened views of specific connector devices 10, 10' of the present invention, which have been cut from a solid, cylindrical tube by presently known laser cutting technology.
The tube is preferably formed of resilient or superelastic material, such as a nickel- titanium alloy containing 50.8 atomic nickel/balance titanium.
The showings of Figures 2 and 3 depict preferred connector devices 10, 10' in their radially
12 WO 99/25273 PCTNS98n3916 compact configurations after having undergone a hypothetical flattening maneuver-- i.e., a maneuver whereby a straight cut is formed longitudinally in each device 10, 10a, and the device 10, 10' is then unrolled from its original cylindrical configuration to a flat configuration.
In the embodiment shown in Figure 2, some of the alternating elongate members 16s (i.e., the "selected" alternating elongate members) of each annular member 12a, 12b may be wider in cross-dimension and/or of greater mass than the other alternating elongate members 16n (i.e., the "non-selected" alternating elongate members). Because the selected alternating elongate members 16s are wider and/or of greater mass than the other non-selected alternating elongate members 16n, the selected alternating elongate members 16s will diverge (i.e., separate or spread) further away from each other than will the non-selected alternating members 16n, as the device 10 or 10' self expands to its radially expanded configuration. As a result, the corresponding selected strut members 14s which are attached to the apices 20s of the selected alternating elongate members 16s, will also separate further apart than the other non-selected strut members 14n. Thus, when the device 10 is in its radially expanded implantation configuration, the separation distance DS between the selected struts 14s will be greater than the separation distance D"
between non-selected struts 14n. In this manner, the device 10 may be implanted in a specific rotational orientation wherein the intended flow of blood or other body fluid will pass between the selected struts 14s and the increased separation distance D, therebetween will minimize the fi~ictional drag or disruption of flow which would or could occur if the selected struts 14s were within the fluid flow path. Although this aspect of the invention is shown in relation to Figure 2, it will be appreciated that this aspect of the invention may be incorporated into any embodiment of the two-annular member or three-annular member connector drvice 10, 10' wherein the structure of the device will permit.
The strut members 14 may be rigidly connected to (e.g., formed continuously with or fiised to) the inboard apices 20 of the annular members 12a,12b as shown in Figure 2, or alternatively such strut members 14 may be flexibly connected to (e.g., connected by hinged or pivotal connection) to the inboard apices 20 as shown in Figure 2a. In embodiments wherein the strut members 14 are rigidly connected to the inboard apices 20, it will be desirable for the strut members to be formed or formable to a curved (e.g. serpentine) shape which conforms to the shape of the surrounding anatomy at the intended site of implantation. In other embodiments wherein the strut members 14
13 are flexibly connected to the inboard apices 20, the strut members may be formed or fonnable to a straight or minimally curved configuration to facilitate transluminal delivery of the device 10, as these flexible connections between the strut members 14 and annular members 12a, 12b will automatically pivot or flex so as to conform to the shape of the surrounding anatomy within which the device 10 is implanted. Although this aspect of the invention is shown in relation to Figure 2, it will be appreciated that this aspect of the invention may be incorporated into any embodiment of the two-annular member or three-annular member connector device 10, 10' wherein the structure of the device will permit.
Also, as shown in figures 2b and 2c, some or all of the strut members) 14 rnay be connected to neighboring strut members) 14 by linking members 30a or 30b. These linking members 30a, 30b may serve to selectively control or limit the distance of separation Ds or Dn of the adjacent strut members 14 and/or may provide increased scaffolding to prevent surrounding tissue (e.g., intervening connective tissue or muscle which resides between the anatomical conduits) from lapsing, invading or ingrowing into the flow-through space FS. As shown in Figures 2b and 2c these linking members 30a, 30b may be of curved or V-shaped configuration, and those linking members 30a in one portion (e.g., the proximal half) ofthe connector dovico 10 may bo directed in a direction X , which is opposite the direction Y in which those linking members 30b in another portion of the connector device (e.g., the distal half) are directed. The acute intenlal angle of each such "V" shaped linking member 30a, 30b will decrease as the separation distance Ds between the adjacent strut members 14 increases. Although this aspect of the invention is shown in relation to Figure 2, it will be appreciated that this aspect of the invention may be incorporated into any embodiment of the two-annular member or three-annular member connector device 10, 10' wherein the structure of the device 10, 10' will permit.
Also, as shown in Figure 2d, some or all of the strut members 14 may incorporate spaced-apart curved segments 32 which diverge laterally from the longitudinal axis AX,~"~ of the strut 14.
These curved segments 32 may be arcuate (e.g., generally U shaped) and may be spaced equidistantly from one another. These curved segments 32 provide increased scaffolding to prevent surrounding tissue (e.g., intervening connective tissue or muscle which resides between the anatomical conduits) from lapsing, invading or ingrowing into the flow-through space FS.
14 WO 99lZ5273 PCT/US98/23916 In the preferred connector device 10' shown in Figure 3, the strut members 14b which extend from the distal annular member 12b pass longitudinally through the medial annular member 12c and are attached thereto at locations L on the proximal aspect of the medial annular member 12c, thereby causing the structure of the medial annular member 12c to be more dense (i.e., less porous) S than the proximal or distal annular members 12a, 12b. Such increased density of the medial annular member will provide a regionalized increase or concentration of scaffolding to prevent tissue which surrounds the medial annular member 12c (e.g., intervening connective tissue or muscle which resides between the anatomical conduits) finm lapsing, invading or ingrowing into the flow-through space FS which passes through the medial annular member 12c. This optional aspect of the invention may be particularly desirable in applications where the tissue which surrounds the medial annular member I2c is likely to undergo proliferation (e.g., formation of granulation tissue) or in-growth which could occlude or decrease the patency of the flow space FS.
Although this aspect of the invention is shown specifically in relation to Figure 2, it will be appreciated that this aspect of the invention may be incorporated into any embodiment of the two-annular-member or three-annular-member connector device 10, 10' wherein the structure of the device 10, 10' will permit.
As also shown in Figure 3, in some embodiments of the invention, some of the strut members 14a (crv), 14b (crv) may be longer than the other strut members 14a, 14b, and may incorporate one or more waves or curves while in they pre-expansion configuration. These strut members 14a (crv), 14b (crv) will typically be required to navigate a larger radius of curvature than the other strut members 14a, I4b which are located laterally across from them.
Thus, these strut members 14a (crv), I4b (crv) have a curve or wave fonm built in while in their pre-expansion configurations, and such curve or wave form will elongate (e.g., relax or become shallower) as the device 10 transitions to its expanded, implantation configuration and the excess length of those strut members 14a (crv), 14b (crv) which become elongated will accommodate the increased radius of curvature which they are required to navigate as device 10 is implanted.

qrp 99/2~~3 - PCT/US98/23916 B. Methods and Devices for Precise Rotational Orientation of Delivery Catheter used for Implantation of Connector Devices Having Preformed Curved Configuration.
In embodiments of the invention wherein the connector device 10, 10' has a preformed, curved configuration as shown in Figure 1 c, it will often be desirable to preposition the delivery catheter used to deliver the connector device 10, 10' in a specific rotational orientation to ensure that the connector device 10, 10' will be properly oriented when it is expelled from the delivery catheter 48.
i. Marker(s) on Delivery Catheter Markers on the delivery catheter 48 may be specifically positioned and/or configured to provide an indication of the longitudinal placement of the connector 10, 10' within the catheter.
Such markers may then be utilized as the delivery catheter 48 is placed across the passageway between the anatomical conduits, to allot the operator to determine where the ends of the connector device 10, 10' will ultimately be placed when the device 10, 10' is implanted.
Additionally, the delivery catheter 48 may incorporate at least one marker 50 which indicates the particular rotational orientation in which the connector device 10, 10' has been loaded into the catheter 48. As shown in Figures 4a-4c, such marker 50 may comprise a band having a notch 52 fonmed at a specific location thereon. The band of this marker 50 may be formed of any suitable material capable of being imaged or detected by the type of imaging or detection system being used (e.g., x-ray, fluoroscopy, ultrasound, Doppler, MRI, etc.) For example, the marker 50 may be formed of radiopaque or radiodense metal or plastic which may be imaged by fluoroscopy. The location of the notch 52 signifies or marks a predetermined location or point P on the connector device 10, 10'.
ii. Markers) on Connector Device At least one second imagable marker 23 capable of being imaged by the particular imaging system avaliable dicing the procedure (e.g., x-ray, fluoroscopy, ultrasound, Doppler, MRI, etc.) may be formed on the distal end of the connector device 10, 10' at location P.
These markers 23, 50 may then be used by the operator to facilitate implantation of a device 10, 10' having a preformed curvature, in its proper orientation of curvature, as illustrated by Figures Sa-Sc and described more fully herebelow.
iii. Method for Using Markers to Ensure Correct Rotational Orientation of Preformed Connector Device Prior to Implantation With particular reference to Figures Sa-Sc, a connector device 10 having strut members 14 which are preformed to a desired curvilinear configuration, is preferably sufficiently resilient to be compressible to a substantially straight, radially compact configuration whereby it may be loaded into the lumen of a delivery catheter 48. When the device 10 is loaded into the delivery catheter 48, a core member 54 will be positioned within and/or behind the device 10 to prevent the connector device 10 from retracting in the proximal direction within the delivery catheter 48.
The connector device 10 having prefonned curved strut members 14 may be oriented within the catheter 48 such that the second marker 23 on point P of the connector device 10 is next to the notch 52 of the catheter marker 50. The catheter 48 is then advanced through the lumen of a first anatomical conduit AC, , through previously formed openings OP,, OPZ, and into the lumen of the second anatomical conduit ACZ, as shown in Figure Sa., Thereafter, the catheter 48 is rotated under radiographic visualization (e.g., fluoroscopy) until the notch 52 of marker 50 is located adjacent the wall of the second anatomical conduit AC2 directly (i.e., 180 degrees) opposite the location of the second opening OP2, Thereafter the core member 54 is held in longitudinally fixed position the prevent proximal retraction of the connector device 10, and the catheter 48 is slowly retracted in the proximal direction. As the catheter 48 is retracted, the first annular member 12a will initially become uncovered by the catheter 48 such that it may radially expand. As the distal end of the first annular member 12a is uncovered by the retracting catheter 48, the operator may check the position of the marker 23 on the distal end of the device 10 (i.e., on the distal annular member 12a) to confirm that the device 10 is in its desired rotational orientation. If the rotational orientation of the device is determined to be improper, the operator may halt further retraction of the catheter 48 and may make fiuther adjustment of its rotational orientation before the first annular member 12a becomes fully radially expanded. After the proper rotational orientation of the connector device 10, 10' has been confirmed by the positioning of the second marker 23, the catheter 48 will be further retracted such that the curved struts) 14 and any third annular member 12c (if present) extend as desired WO 99/25273 ~ PCT/US98/23916 through the openings OP, , OPZ and the second annular member 12b becomes deployed and radially expanded within the lumen of the second anatomical conduit ACZ .
Those skilled in the art will recognize that these aspects of the present invention, and particularly the use of visible markers to effect the desired orientation and positioning of the S connector device 10 at the time of implantation, may be accomplished in accordance with the catheter-orienting/ positioning techniques (e.g., techniques which use an accompanying intravascular ultrasound imaging catheter (IVUS)) described in co-pending United States Patent Application Serial No. 08/837, 294 filed on April 11, 1997, the entire disclosure of such co-pending application being expressly incorporated herein by reference.
C. Full or Partial Covering of Connector Devices As shown in Figure 6a-6b, any of the two-annular member or three-annular member connector devices 10 (covered) may be fully or partially covered by a pliable covering 60, 60 (partial). Such covering 60, 60(partial) may be formed of any suitable material, such as a polymer film (expanded polytetrafluoroethylene (ePTFE) or polyurethane) or a fabric (e.g., woven polyester).
Such covering 60, 60(partial) may be disposed upon and supported by the annular members 12a, 12b, 12c and/or the strut members 14a, 14b, 14a (crv), 14b (crv). Such covering 60, 60(partial) may form a barrier about all or a portion of the flow space FS defined within the connector device 10 (covered). In this regard, such optional covering 60, 60(partial) may serve to: i) prevent direct contact between the annular members 12a, 12b, 12c and/or strut members 14a, 14b, 14a(crv), 14b(crv) and the adjacent host tissue to i) improve the biocompatability of the connector device 10(covered), ii) minimize the potential for immunologic graft-host responses;
iii) prevent body fluid from leaking or infiltrating into spaces or tissues which surround the connector device 10 (covered);
iv) channel or direct the flow of body fluid in desired directions or into desired anatomical structures;
v) prevent or deter tissue proliferation, ingrawth or invasion of tissue into the flow space FS defined within the connector device 10(covered) andlor vi) distribute any outwardly directed force created by the connector device 10, 10' over the adjacent surface of the anatomical conduit(s), thereby minimizing the potential for Localized erosion or perforation of the anatomical conduits by the implanted connector device 10(covered). Also, in some embodiments such as that shown in Figure 11, the covering 60, 60 (partial) may extend transversely through the device, or may be otherwise WO 99/25273 PCT/US98~23916 positioned, to fully or partially block the flow of body fluid (e.g., blood) in a certain direction or through a certain portion of the device.
The physical and material properties of the covering 60, 60 (partial) my vary depending on the intended application and mode of deployment of the device 10 (covered). In some embodiments, the covering 60 may be formed of material which is sufficiently elastic to expand to the radially expanded diameter of the device 10(covered) and to contract to the radially contracted diameter of the device 10(covered) without creating substantial slack in the material of the covering 60. In other embodiments wherein the covering 60 does not have such range of elasticity, it is preferable that the covering 60 be attached to or disposed on the annular members 12a, 12b, 12c and or the strut members 14a, 14b, 14a(crv), 14b(crv) such that any slack which forms when the device 10(covered) is in its radially compact configuration, may be folded, furled or compressed in a manner which will reduce such slack to a small diameter close to or equal to that of the radially compact annular members 12a, 12b, 12c, thereby facilitating the desired transluminal passage of the device 10(covered).
In some embodiments, the full or partial covering 60, 60 (partial) may be formed of material which is capable of being imaged by the type of imaging system being utilized during the procedure (e.g., x-ray, flouroscopy, MRI, ultrasound, Doppler, etc.). For example, the covering 60, 60(partial) may be impregnated with BaS04 so as to be radiographically imaged, thereby allowing the operator to place the cover 60, 60(partial) in a desired location, and also allowing the cover 60, 60(partial) to continue to act as a marker of a specific location (e.g., the location of a flow-through passageway between anatomical conduits) subsequent to completion of the interventional procedure.
D. In Situ Modification of the Strut Members) and/or Covering to Form or Promote A Desired Flow Path Through the Connector Device Figures 7a-7e show a method which may be used for forming openings) in the plaiable cover 60 of a covered connector device 10 (covered). It will be further appreciated, however, that this method may also be used to effect in situ deformation or separation of adjacent strut members 14a, 14b, 14a (crv), 14b (crv) of any connector device 10, 10', 10 (covered) in order to promote nonturbulant, laminar flow of body fluid (e.g., blood) between those strut members 14a, 14b, 14a (crv), 14b(crv).
Referring to Figure 7a, after the connector device 10 (covered) has been implanted in the desired first and second anatomical conduits AC1, AC2, a separate catheter 66 having a cover-puncturing distal tip 67 and a balloon 68 may be advanced through the covering 60 at a desired location (see Fig. 7b) and the balloon 68 may then be inflated to form a desired flow-through opening 62a, 62b in the covering 6(? of the connector device 10 (covered). It is to be appreciated that, although figures 7a-7e show a procedure for the in situ formation of flow-through openings 62a, 62b in the covering 60, essentially the same procedure using the catheter 66 (without the puncturing distal tip 67) and its balloon 68 may be used to accomplish in situ bending or deformation of the strut members 14, 14a, 14b, 14a(crv}, 14b(crv) of any covered connector device 10 (covered) or noncovered connector device 10, 10' of the present invention, for the purpose of improving flow of body fluid, or improving the stability with which the device 10, 10' , 10(covered) is implanted.
E. Use of the Connector Devices to Exert Traction Upon or Cause Deformation of Surrounding Tissue In some applications of the invention, it may be preferable for the connector device 10, 10', 10 (covered) to exert some traction or force upon surrounding tissues to modify (e.g., remodel, move, reconfigure, compress or otherwise reshape) the surrounding tissues.
This aspect of the invention may be particularly useable to minimize the sharpness of corners or bends in an anatomical flow channel or passageway so as to minimize turbulence and/or promote laminar flow through the channel or passageway. In some instances, the desired traction force may be created by implanting two (2) of the connector devices 10, 10', 10 (covered) in opposite orientations, as described more fully in the examples provided herebelow.
In other applications where the un-scaffolded channels or passageways have been formed at the desired angle (e.g., a non-perpendicular angle relative to the longitudinal axis of one of the anatoriiical conduits), and the curved shape of the connector devices) 10, Z
O' and/or the placement of the connector devices 10, 10' in opposite orientations, may be utilized as a means of minimizing WO 99/25273 ~ PCT/US98lZ3916 the amount of traction upon, or the deformation of, the surrounding tissue.
i. A method wherein a single delivery catheter is used to implant two connector devices, in opposite orientations:
S Figures 8a-8e show an example of an approach wherein a single delivery catheter 48 is used to deliver and implant two (2) connector devices 10 in opposite orientations, as shown.
In addition to l.) holding the adjacent anatomical conduits AC,, ACZ in desired positions relative to each other and ii.) maintaining the patency of the openings OP,, OPZ in the anatomical conduits AC,, ACz and any intervening tissue positioned therebetween, the connector devices 10, 10' of the present invention may additionally create a desired traction force upon the openings OP,, OPz and any surrounding or adjacent tissue, to effect a desired deformation or shaping of the flow passageways created between the anatomical conduits AC,, AC2. Such deformation or shaping of the flow passageways may serve to minimize turbulence of the body fluid (e.g.
blood) as it flows through the in situ bypass conduit created by a segment of the second anatomical conduit AC,, AC2.
Figure 8a shows the use of a passageway forming catheter 80 which has been advanced into a vein V and which has a tissue penetrating element 82 extendable laterally therefrom, to foam two (2) interstitial blood flow passageways or openings OP,, OPz between the vein V and an adjacent artery A, for the purpose of bypassing an obstruction OB in the artery A in accordance with the transluminal, in situ bypass method described in copending United States Patent Application Serial No. 08/730, 327 and 08/730, 496. As shown, the axes AX,, AXZ of the interstitial blood flow passageways or openings OP,, OPZ are initially parallel or substantially parallel to each other, at varying distances. It will be appreciated that the same openings OP,, OPi could be formed by passing the passageway forming catheter 82 through the artery A (if the obstruction is of a type which will permit such catheter 82 to be passed therethrough) or by placing a first passageway forming catheter 82 in the artery A and a second passageway forming catheter 82 in the vein V as shown in Figure 9a described herebelow.
After these bloodflow passageways or openings OP,, OPZ have been formed, it may be desired to cause such interstitial blood flow passageways or openings OP,, OPZ
to become nonparallel (e.g., to angle inwardly toward one another, in order to promote laminar, nonturbulent blood flow through the segment of the vein V being used as the bypass conduit). To facilitate such alteration or angular disposition of the blood flow passageways or openings OP,, OPz, two (2) connector devices 10 of the present invention will be implanted in opposite orientations, so as to exert traction upon the surrounding tissues and to cause such modification of the openings or passageways OP,, OPz, as illustrated in Figures 8b-8e.
Initially, as shown in Figure 8b, the connector device delivery catheter 48 is advanced over a guidewire GW from the artery A, through the first blood flow passageway or opening OP,, through the bypass segment of the vein V, back through the second blood flow passageway or opening OPZ, and into the artery A distal to the obstruction OB.
Thereafter, as shown in Figure 8c, the delivery catheter 48 is slowly withdrawn through the second blood flow passageway or opening OPz while the distal connector device 10 is implanted within the second blood flow passageway or opening OPT in the orientation shown in figure 8c.
Thereafter, as shown in Figure 8d, the delivery catheter 48 is further withdrawn through the first blood flow passageway or opening OP,, while the proximal connector device 10 is implanted in the first blood flow passageway or opening OP, in the opposite orientation shown in Figure 8d.
Such implantation of the two connector devices 10 in opposing orientation causes traction to be exerted on the surrounding tissue and results in angulation of the blood flow passageways or openings OP,, OPz such that the axes AX,, AXz are no longer substantially parallel to each other, but rather are angled toward each other as shown in Figure 8e, thereby lessening the potential for disruption or turbulence of blood as it flows through the blood flow passageways or openings OP,, OP2 in the manner indicated by the arrows on Figure 8e.
ii. Methods wherein two delivery catheters are used to implant two connector devices, in opposite orientations:
Figures 9a-9e and l0a-10j show two (2) examples of alternative approaches which may be used to implant two (2) of the connector devices 10 in opposing directions, as was accomplished in the procedure shown in Figures 8a-8e described hereabove. In these alternative approaches two (2) delivery catheters are used to deliver and implant the two (2) connector devices 10, as shown.

WO 99/25273 PCT/US98n39I6 The Method Shown in Figures 9a-9e Figure 9a shows the use of a passageway forming catheter 80 which has been advanced into a vein V and which has a tissue penetrating element 82 extendable laterally therefrom, to form two (2) interstitial blood flow passageways or openings OP,, OP, between the vein V and an adjacent artery A, for the purpose of bypassing an obstruction OB in the artery A in accordance with the transluminal, in situ bypass method described in copending United States Patent Application Serial No. 08/730, 327 and 081730, 496. As shown, the axes AX,, AXZ of the interstitial blood flow passageways or openings OP,, OPZ are initially parallel or substantially parallel to each other.
In this particular application of the technology, it is desired to cause the interstitial blood flow passageways or openings OP,, OPZ to become nonparallel and to angle inwardly toward one another, in order to promote laminar, non-turbulent blood flow through the segment of the vein V being used as the bypass conduit. To facilitate such non-parallelism or angular disposition of the blood flow passageways or openings OP,, OPZ _ two (2) connector devices 10 of the.present invention will be inplanted in opposite orientations, as shown in Figures 9b-9e.
Initially, as shown in Figure 9b, a first connector device delivery catheter 48a is advanced aver a guidewire GW into the vein V, and is used to place a connector device 10 within the second blood flow passageway or opening OPZ, between the artery A and vein V, distal to the obstruction OB.
Thereafter, as shown in Figure 9c, a second delivery catheter 48b is used to place a connector device 10 within the first blood flow passageway or opening OP2, in the opposite orientation shown in Figure 8d.
Such implantation of the two connector devices 10 in opposing orientation causes traction to be exerted on the surrounding tissue and results in angulation of the blood flow passageways or openings OP,, OPZ such that the axes AX,, AXZ are no longer substantially parallel to each other, but rather are angled toward each other as shown in Figure 9e, thereby lessening the potential for disruption or turbulence of blood as it flows through the blood flow passageways or openings OP,, OP, in the manner indicated by the arrows on Figure 9e.

WO 99/25273 PGT/US98n3916 The Method Shown in Figures l0a-IOi Figure l0a shows the use of a passageway forniing catheter 80 which has been advanced into a vein V and which has a tissue penetrating element 82 extendable laterally therefrom, to form two (2) interstitial blood flow passageways or openings OP,, OPZ between the vein V and an adjacent artery A, for the purpose of bypassing an obstruction OB in the artery A in accordance with the transluminal, in situ bypass method described in copending United States Patent Application Serial No. 08/730, 327 and 08/730, 496. As shown, the axes AX,, AXZ of the interstitial blood flow passageways or openings OP,, OPZ are initially parallel or substantially parallel to each other.
As in the above-described examples of Figures 8a-8e and 9a-9e, it is desired to cause the interstitial blood flow passageways or openings OP,, OPZ to become nonparallel and to angle inwardly toward one another, in order to promote laminar, non-turbulent blood flow through the segment of the vein V being used as the bypass conduit. To facilitate such non-parallelism or angular disposition of the blood flow passageways or openings OP,, OP2 two (2) connector devices 10 of the present invention will again be inplanted in opposite orientations.
Initially, as shown in Figures l Ob and lOc, a first connector device delivery catheter 48a is advanced over a guidewire GW into the vein V, and is used to place a connector device 10 within the second blood flow passageway or opening OPZ, between the artery A and vein V, distal to the obstruction OB.
Thereafter, as shown in Figures l Od -l Og, a guidewire GW is advanced into the atrery A such that the distal end of the guidewire GW is located next to the proximal passageway or opening OP,.
A guidewire captureing catheter 100 having a guidewire capturing apparatus 102 advanceable therefrom, is advanced into the vein V adjacent to the first passageway or opening OP,, and the guidewire capturing apparatus 102 is advanced through the first passageway or opening OP, and is used to capture the guidewire GW at a location near its distal end, as shown.
Thereafter, the guidewire capturing apparatus 102 and/or catheter 100 is/are manipulated and/or retracted to pull the distal end of the guidewire GW through the first passageway or opening OP, such that the distal end of the guidewire GW is positioned within the vein V, distal to the first passageway or opening OP,, as shown. The guidewire capturing apparatus used in this step of the procedure may be any type of member or apparatus which is useable for this purpose, including but not limited to intraluminal snares and graspers of the type well known in the field of interventional radiology. Examples of commercially available snares or graspers which may be useable or modifiable for this application include the Cordis BI PAL formable/torquable disposable biopsy forceps(Cordis -----, Miami, FL);
the BYCEP P.C. pre-curved biopsy forcep (Mansfield-Boston Scientific Corporation, Watertown, MA); the Intravascular Snare (Cook, Inc., Bloomington, IN); and the Microvena Retrieval Snare (Microvena, Corporation, White Bear Lake, Ml~.
Thereafter, as shown in Figure l Oh-l Oj, a second delivery catheter 48b is advanced through the artery A, over the guidewire GW, and through the first passageway or opening OP, and is used to place a second connector device 10 within the first blood flow passageway or opening OP,, in the opposite orientation shown in Figure 8d.
Such implantation of the two connector devices 10 in opposing orientation causes traction to be exerted on the surrounding tissue and results in angulation of the blood flow passageways or openings OP,, OPz such that the axes AX,, AXZ are no longer substantially parallel to each other, but rather are angled toward each other as shown in Figure 10e, thereby lessening the potential for disruption or turbulence of blood as it flows through the blood flow passageways or openings OP,, OPZ in the manner indicated by the arrows on Figure 10e.
F. Use of a Partially Covered Connector Device to Block Outflow through Side Branches which Emanate From the Anatomical Conduits) Figures l la-lle show an example of a procedure wherein a single, partially covered, connector device 10 (covered) is used to simultaneously a) maintain flow through first and second bloodflow passageways or openings OP, , OP2 and b) block the outflow of blood through venous side branches SB which emanate from the segment of vein V being used as an in situ bypass conduit.
Initially, as shown in Figure l la, a passageway forming catheter 80 is utilized to form first and second bloodflow passageways or openings OP, , OP 2 between an artery A
and vein V. As discussed hereabove with reference to Figures 8a-8d, 9a-9e, and l0a-10j, the passageway forming catheter 80 may alternatively be passed into the artery A or into both the artery A and vein V to create the form these bloodflow passageways or openings OP, , OP Z having axes AX, ,AX 2 which are substantially parallel to each other, as shown in Figure I la.

WO 99/25273 PCTNS98n3916 Thereafter, as illustrated in Figure 1 lb a guidewire GW is advanced through the artery A, through the first passageway or opening OP,, through the adjacent segment of the vein V, and through the second passageway or opening OPZ, such that the distal end of the guidewire GW is located in the artery A downstream of the obstruction OB. A connector device delivery catheter 48 having the a single, partially covered, connector device 10 (covered) loaded therein is then advanced over the guidewire until the distal end of the delivery catheter 48 is also in the artery A, downstream of the obstruction OB, as shown.
Thereafter, as shown in Figures l lc-l ld, the connector device 10 (covered) is advanced out of the distal end of the delivery catheter 48 as the delivery catheter is slowly retracted. This results in the single connector device 10 (covered) being implanted such that its distal annular member 12 b is positioned within the artery A downstream of the obstruction, its proximal annular member 12a is positioned within the artery A upstream of the obstruction, and its strut members 14 extend through the first and second passageways or openings OP, , OP2, and through the segment of vein V being used as the in situ bypass conduit.
As shown in Figure 11 e, the partial covering 59 disposed on one side of the strut members 14 of the connector device 10 (covered) is positioned in contact with the adj scent wall of the vein V so as to prevent blood from flowing into any venous side branch SB which emanates from that portion of the vein V. Additionally, the partial covering 59 blocks the flow of venous return through the portion of the vein V being used as the in situ bypass conduit. Also, as shown, this disposition of a single, partially covered, two-annular-member connector device 10 (covered) exerts traction upon the surrounding tissue so as to cause the axes AX, ,AXZ of the passageways or openings OP, OP2 to angle inwardly such that they are no longer parallel. This serves to minimize turbulence of the blood flowing through this bypass conduit.
G. Implantation of the Connector Devices within Bifurcated Anatomical Conduits Figure 12 shows an example of the manner in which a two-annular-member connector device 10 of the present invention may be implanted within a bifiucated vessel. As shown, the main vessel MV bifurcates into a first branch BRl and a second branch BR2. The connector device 10 is positioned such that its proximal annular member 12a is in the main vessel MV, its distal annular WO 99/25273 ' PCTNS98123916 member 12b is in the second branch vessel BR2 and its strut members 14 extend therebetween.
H. Connector Devices having Additional Annular Members It will be appreciated that the two-annular-member connector device 10 has at least two annular members 12a, 12b, hut may include more. Likewise, the three-annular-member connector device 10' has at least three annular members 12a, 12b, 12c, but may include more. Examples of three-annular-member connector devices which incorporate more that thee annular members 12a, 12b, 12c, are shown in Figures 1 S and 16. As shown, depending on the positioning of the device 10' following implantation, the additional proximal, distal or medial annular members 12a,12b,12c may serve to provide additional scaffolding or support for the anatomical conduits AC, , AC 2 or the interstitial passageways formed therebetween.
I. Variable Positioning of the Connector Devices to Accommodate Anatomical Differences and/or to Effect Specialized Therapeutic Applications The connector devices 10, 10', 10 (covered) may be implanted at various locations and/or positions to achieve the desired therapeutic result (e.g., to facilitate flow of body fluid in the desired directions) through the desired conduits/passageways). As shown in many of the figures, including Figures 1 a, lb, 8e, the connector device 10,10',10 (covered) may be implanted such that its opposite ends extend into the first and second anatomical conduits AC, , ACZ and its midportion extends through a passageway which has been formed between those anatomical conduits.
In other applications, as illustrated in Figures 15-17, the connector device 10, 10', 10 (covered) may be implanted such that it extends through multiple interstitial passageways, and/or so that it does not extend into specific regions of the anatomical conduits AC, , ACZ .
It is to be fiuther understood that the diameters or sizes of the annular members 12a,12b,12c of a single device 10, 10', 10(covered) may vary when in their radially expanded states. Such variation in the diameters or sizes of the annular members 12a, 12b, 12c may be utilized to accommodate vessels or passageways of varying size. (e.g., a vein of one diameter and an adjacent artery of another diameter).

J. A Method for Coronary Revascularization within the Trangie of Brouck-Moschesu Using Connector Devices of the Present Invention Figure 18 is a diagram of a portion of the coronary vasculature known as the Triangle of Brouck-Moscheau. The Triangle of Brouck-Moscheau is defined by the left anterior descending oronary artery LAD, the circumflex coronary artery CIR, the anterior interventricular vein AN and the great cardiac vein, GCV, as shown. In the case illustrated in Figure 18, an obstruction OB, such as a build-up of atherosclerotic plaque, is found in the proximal portion of the left anterior descending artery LAD. A revascularization procedure has been carried out to bypass such obstruction OB in the left anterior descending artery LAD by forming a first interstitial passageway or opening OP, between the circumflex artery CX and the Great Cardiac Vein GCV, and a second interstitial passageway or opening OP, between the Anterior Interventricular Vein AN and the Left Anterior Decending artery LAD, downstream of the obstruction OB. A first lumen blocking member SOa has been placed within the great cardiac vein GCV, proximal to the first passageway or opening OP, and a second lumen blocking member SOb has been placed within the anterior 1 S interventricular vein AN, distal to the second passageway or opening OPz such that arterial blood from the circumflex artery CIR will flow through the first blood flow passageway 10a, through the great cardiac vein GCV, through the anterior interventricular vein AIV and into the left anterior descending artery LAD, downstream of the obstruction. One connector device of the present invention 10 has been implanted, in a generally U-shaped configuration, within the first passageway or opening OP, and another connector device 10 has been implanted, in a generally serpentine or "S"
shaped configuration within in the second interstitial passageway or opening OP,. These connector devices serve to maintain patency and allignment of the passageways or openings OP,, OPZ such that blood will continue to freely flow through the adjacent segment of the Great Cardiac Vein GCV/Anterior Interventricular Vein AIV, thereby bypassing the obstruction OB
and providing restored arterial bloodflow to the portion og the Left Anterior Decending artery downstream of the obstruction.
The connector device 10 positioned in the first passageway or opening OP, may be preformed to the desired "U" and expelled from a delivery catheter which has been advanced into the Great Cardiac Vein GCV and at least partially through the first passageway of opening OP, , such that the connector 10 will resiliently assume the "LJ"configuration shown in Figure 17.
The other connector device positioned within the second passageway or opening OP2 may be preformed to a serpentine or "S" shaped configuration and may be implanted by the technique shown in Figures Sa-Sc and described in detail hereabove.
S It will be appreciated that the invention has been described hereabove and shown in the drawings with reference to certain presently preferred embodiments or examples only and no attempt has been made to exhaustively describe all possible embodiments and examples of the invention. Indeed, those skilled in the relevant art will understand that numerous modifications may be made to the above-described embodiments and examples without departing from the intended spirit and scope of the invention, and it is intended that all such modifications be included within the scope of the following claims.

Claims (58)

WHAT IS CLAIMED IS:
1. A device for facilitating flow fluid between a first opening formed in an anatomical conduit and a second opening formed in an anatomical conduit, said device comprising:
at least one proximal annular member and at least one distal annular member, each of said annular members having a radially compact configuration and a radially expanded configuration;
at least one strut member connected to and extending between said proximal and distal annular members, said at least one strut member having a pre-expansion configuration and a post-expansion configuration;
said device being initially transluminally deliverable with its annular members in their radially collapsed configurations and said at least one strut member is in its pre-expansion configuration; and, said device being thereafter implantable with its annular members are in their radially expanded configurations and said at least one strut member is in its post-expansion configuration.
2. The device of Claim 1 wherein the proximal and distal annular members are coaxially positioned during transluminal delivery of the device.
3. The device of Claim 1 wherein the proximal and distal annular members have different longitudinal axes after the device has been implanted.
4. The device of Claim 1 wherein said at least one strut member comprises a plurality of strut members.
5. The device of Claim 2 having 4 to 8 strut members.
6. The device of Claim 2 wherein said strut members are spaced apart from each other and disposed about a central axis when the device is in its implanted, such that a hollow channel is defined within said strut members.
7. The device of Claim 1 wherein said at least one strut member is formed of resilient material such that it remains in its pre-expansion configuration when radially constrained, but will assume its post-expansion configuration when radially unconstrained.
8. The device of Claim 7 wherein said resilient material is selected from the group of resilient materials consisting of:
spring metal;
a resilient polymer, and, a shape memory alloy.
9. The device of Claim 1 wherein said at Least one strut member(s) is/ are formed of malleable material .
10. The device of Claim 9 wherein said malleable material is selected from the group of malleable materials consisting of:
plastically deformable metal; and, plastically deformable polymer.
11. A system comprising the device of claim 10 in combination with:
a pressure-exerting member positioned within said device and useable to cause the annular members to radially expand and the at least one strut member to deform from its pre-expansion configuration to its post-expansion configuration.
12. The system of Claim 11 wherein said pressure-exerting device is a balloon which has a curved configuration when inflated to deform said strut members to a curvilinear post-expansion configurations.
13. The device of Claim 1 wherein said annular members are self expanding.
14. The device of Claim 13 wherein said self expanding annular members are formed of resilient material and are biased to their radially expanded configurations.
15. The device of Claim 14 wherein said resilient material is selected from the group consisting of:
spring metal;
resilient polymer; and, shape memory alloy.
16. The device of Claim 1 wherein said annular members are pressure-expandable.
17. The device of Claim 16 wherein said pressure-expandable annular members are formed of malleable material capable of being plastically deformed from their radially compact configurations to their radially expanded configurations.
18. The device of Claim 17 wherein said malleable material is selected from the group of malleable materials consisting of:
plastically deformable metal; and plastically deformable polymer.
19. The device of Claim 1 wherein said at least one strut member has first and second ends, said first and second ends being fused to said first and distal annular members.
20. The device of Claim 19 wherein said at least one strut member has first and second ends which are connected to said first and distal annular members by flexible connections.
21. The device of Claim 19 wherein loops are formed on the first and second ends of said at least one strut member, and portions of said first and distal annular members are captured within said loops, to thereby form said flexible connections between the ends of said at least one strut member and first and distal annular members.
22. The device of Claim 1 wherein the curvilinear post-expansion configuration of said at least one strut member is a serpentine configuration.
23. The device of Claim 1 wherein the curvilinear post-expansion configuration of said at least one strut member is a generally U shaped configuration.
24. The device of Claim 2 further comprising:
a plurality of transverse strut connector members formed between adjacent ones of said strut members.
25. The device of Claim 2 wherein outer ones of said strut members have a longer radius of curvature than inner ones of said strut members when the device is in its second condition, and wherein said outer ones of said strut members are longer in length than said inner ones of said strut members, said outer ones of said strut members having at least one wave formed therein while the device is in its first condition.
26. The device of Claim 1 further comprising a pliable covering formed on at least a portion of said device.
27. The device of Claim 26 wherein said pliable covering is a generally cylindrical covering formed about said device, said cover defining a hollow lumen which extends longitudinally through the device.
28. The device of Claim 26 wherein at least one flow-through opening is formed in said pliable covering.
29. The device of Claim 26 wherein said pliable covering is formed transversely across the device to block flow of body fluid.
30. The device of Claim 1 wherein said at least one strut member has a post-expansion configuration which is multicurvate, such that said proximal and distal annular members may be positioned at spaced-apart locations in the same anatomical conduit and said at least one strut member may extend through said first and second openings and through a segment of an adjacent second anatomical conduit.
31. The device of Claim 1 wherein at least some of the proximal and distal annular members are of differing size when in their radially expanded configurations.
32. A device for facilitating fluid flow between the lumen of a first anatomical conduit which has a first opening formed therein, and the lumen of a second anatomical conduit which has a second opening formed therein, said device comprising:
at least one proximal annular member, at least one distal annular member and at least one medial annular member, each of said annular members having a radially compact configuration and a radially expanded configuration;
at least one first strut member connected to and extending between said proximal and medial and medial annular members, said at least one first strut member having a pre-expansion configuration and a post-expansion configuration;
at least one second strut member connected to and extending between said medial and distal annular members, said at least one second strut member having a pre-expansion configuration and a post-expansion configuration;
said device being initially transluminally deliverable with its annular members in their radially collapsed configurations and said first and second strut members in their pre-expansion configurations; and, said device being thereafter implantable with its annular members in their radially expanded configurations and its first and second strut members in their post-expansion configurations.
33. The device of Claim 32 wherein the proximal, distal and medial annular members are coaxially positioned during transluminal delivery of the device.
34. The device of Claim 33 wherein the proximal and distal annular members have different longitudinal axes after the device has been implanted.
35. The device of Claim 32 wherein said at least one first and second strut members comprise a plurality of first and second strut members.
36. The device of Claim 35 having 4 to 8 first strut members and 4 to 8 second strut members.
37. The device of Claim 35 wherein adjacent ones of said first and second strut members are spaced apart from each other and disposed about a central axis when the device is implanted, such that a hollow channel is defined within said strut members.
38. The device of Claim 32 wherein said first and second strut members are formed of resilient material such that they remain in their pre-expansion configurations when radially constrained, but will assume their post-expansion configurations when radially unconstrained.
39. The device of Claim 38 wherein said resilient material is selected from the group of resilient materials consisting of:
spring metal;
a resilient polymer; and, a shape memory alloy.
40. The device of Claim 32 wherein said first and second strut members are formed of malleable material.
41. The device of Claim 40 wherein said malleable material is selected from the group of malleable materials consisting of:
plastically deformable metal; and, plastically deformable polymer.
42. The device of Claim 33 wherein at least some of said proximal, distal and medial annular members a=e of different size when in their radially expanded configurations.
43. A system comprising the device of claim 32 in combination with:
a pressure-exerting member positioned within said device and useable to cause the device to deform and become implanted such that its annular members are in their radially expanded configurations and its first and second strut members in their post-expansion configurations.
44. The system of Claim 43 wherein said pressure-exerting device is a balloon which has a curved configuration when inflated to deform said first and second strut members to their curved post-expansion configurations.
45. The device of Claim 32 wherein said annular members are self expanding.
46. The device of Claim 32 wherein said self expanding annular members are formed of resilient material and are biased to their radially expanded configurations.
47. The system of Claim 46 wherein said resilient material is selected from the group consisting of:
spring metal;
resilient polymer; and, shape memory alloy.
48. The device of Claim 32 wherein said first and second strut members have first and second ends, the first and second ends of said first strut members being fused to said proximal and medial annular members and the first and second ends of said second strut members being fused to said medial and distal annular members.
49. The device of Claim 32 wherein said first and second strut members have first and second ends, the first and second ends of said first strut members are connected to said proximal and medial annular members by flexible connections and the first and second ends of said second strut members are connected to said medial and distal annular members by flexible connections.
50. The device of Claim 49 wherein loops are formed on the first and second ends of said first and second strut members, and portions of said annular members are captured within said loops, to thereby form said flexible connections between the ends of said strut members and said annular members.
51. The device of Claim 32 wherein the post-expansion configuration of said at least one first strut member is curved in a first direction and the post-expansion configuration of said at least one second strut member is curved in a second direction, such that said first and second strut members combine to provide a serpentine configuration.
52. The device of Claim 32 further comprising:
a plurality of transverse strut connector members formed between adjacent ones of said strut members.
53. The device of Claim 32 wherein outer ones of said strut members have a longer radius of curvature than inner ones of said strut members when the device is implanted, and wherein said outer ones of said strut members are longer in length than said inner ones of said strut members, said outer ones of said strut members having at least one wave formed therein while in their pre-expansion configurations.
54. The device of Claim 32 further comprising a pliable covering formed on at least a portion of said device.
55. The device of Claim 54 wherein said pliable covering is a generally cylindrical covering formed about said device, said cover defining a hollow lumen which extends longitudinally through the device.
56. The device of Claim 54 wherein at least one flow-through opening is formed in said pliable covering.
57. The device of Claim 54 wherein said pliable covering is formed transversely across the device to block flow of body fluid.
58. The device of Claim 32 wherein said first and second strut members combine to have a post-expansion configuration which is multicurvate, such that said proximal and distal annular members may be positioned at spaced-apart locations in the same anatomical conduit and said strut member may extend through said first and second openings and into a segment of an adjacent second anatomical conduit with said medial annular member being located within said second anatomical conduit.
CA002308475A 1997-11-14 1998-11-10 Devices for forming and/or maintaining connections between adjacent anatomical conduits Abandoned CA2308475A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/970,694 1997-11-14
US08/970,694 US6432127B1 (en) 1996-10-11 1997-11-14 Devices for forming and/or maintaining connections between adjacent anatomical conduits
PCT/US1998/023916 WO1999025273A1 (en) 1997-11-14 1998-11-10 Devices for forming and/or maintaining connections between adjacent anatomical conduits

Publications (1)

Publication Number Publication Date
CA2308475A1 true CA2308475A1 (en) 1999-05-27

Family

ID=25517341

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002308475A Abandoned CA2308475A1 (en) 1997-11-14 1998-11-10 Devices for forming and/or maintaining connections between adjacent anatomical conduits

Country Status (7)

Country Link
US (1) US6432127B1 (en)
EP (1) EP1037571A4 (en)
JP (1) JP2001522692A (en)
AU (1) AU1392899A (en)
CA (1) CA2308475A1 (en)
IL (1) IL135918A0 (en)
WO (1) WO1999025273A1 (en)

Families Citing this family (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5755682A (en) * 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
US6120432A (en) * 1997-04-23 2000-09-19 Vascular Science Inc. Medical grafting methods and apparatus
US6330884B1 (en) 1997-11-14 2001-12-18 Transvascular, Inc. Deformable scaffolding multicellular stent
US6231546B1 (en) 1998-01-13 2001-05-15 Lumend, Inc. Methods and apparatus for crossing total occlusions in blood vessels
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US6290728B1 (en) 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US6261304B1 (en) 1998-09-10 2001-07-17 Percardia, Inc. Delivery methods for left ventricular conduit
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US7314477B1 (en) 1998-09-25 2008-01-01 C.R. Bard Inc. Removable embolus blood clot filter and filter delivery unit
EP1447058A1 (en) 1998-09-30 2004-08-18 Bard Peripheral Vascular, Inc. Delivery mechanism for implantable stent
US6302892B1 (en) 1999-08-04 2001-10-16 Percardia, Inc. Blood flow conduit delivery system and method of use
US6253768B1 (en) 1999-08-04 2001-07-03 Percardia, Inc. Vascular graft bypass
US6605053B1 (en) 1999-09-10 2003-08-12 Percardia, Inc. Conduit designs and related methods for optimal flow control
US7296577B2 (en) * 2000-01-31 2007-11-20 Edwards Lifescience Ag Transluminal mitral annuloplasty with active anchoring
AU3420201A (en) * 2000-02-07 2001-08-14 S And G Biotech Inc. Blood vessel graft and graft introducer
US6572646B1 (en) * 2000-06-02 2003-06-03 Advanced Cardiovascular Systems, Inc. Curved nitinol stent for extremely tortuous anatomy
US6464665B1 (en) * 2000-07-05 2002-10-15 Richard R. Heuser Catheter apparatus and method for arterializing a vein
FR2813518B1 (en) * 2000-09-04 2002-10-31 Claude Mialhe VASCULAR OCCLUSION DEVICE, APPARATUS AND METHOD OF USE
JP4822626B2 (en) * 2001-07-31 2011-11-24 マニー株式会社 Shunt inserter
US9204956B2 (en) 2002-02-20 2015-12-08 C. R. Bard, Inc. IVC filter with translating hooks
US7572286B1 (en) * 2002-05-13 2009-08-11 Advanced Cardiovascular Systems, Inc. Stent assembly for the treatment of vulnerable plaque
EP1506793B1 (en) * 2002-05-20 2009-08-05 Kawasumi Laboratories, Inc. Stent and stent graft
US20040059406A1 (en) * 2002-09-20 2004-03-25 Cully Edward H. Medical device amenable to fenestration
US7331986B2 (en) * 2002-10-09 2008-02-19 Boston Scientific Scimed, Inc. Intraluminal medical device having improved visibility
US7316710B1 (en) * 2002-12-30 2008-01-08 Advanced Cardiovascular Systems, Inc. Flexible stent
US8500792B2 (en) 2003-09-03 2013-08-06 Bolton Medical, Inc. Dual capture device for stent graft delivery system and method for capturing a stent graft
US11259945B2 (en) 2003-09-03 2022-03-01 Bolton Medical, Inc. Dual capture device for stent graft delivery system and method for capturing a stent graft
US20070198078A1 (en) 2003-09-03 2007-08-23 Bolton Medical, Inc. Delivery system and method for self-centering a Proximal end of a stent graft
US7763063B2 (en) 2003-09-03 2010-07-27 Bolton Medical, Inc. Self-aligning stent graft delivery system, kit, and method
US8292943B2 (en) 2003-09-03 2012-10-23 Bolton Medical, Inc. Stent graft with longitudinal support member
US11596537B2 (en) 2003-09-03 2023-03-07 Bolton Medical, Inc. Delivery system and method for self-centering a proximal end of a stent graft
US20080264102A1 (en) 2004-02-23 2008-10-30 Bolton Medical, Inc. Sheath Capture Device for Stent Graft Delivery System and Method for Operating Same
US9198786B2 (en) 2003-09-03 2015-12-01 Bolton Medical, Inc. Lumen repair device with capture structure
US20050278013A1 (en) * 2004-05-26 2005-12-15 Matthew Rust Method for endovascular bypass stent graft delivery
US7704267B2 (en) 2004-08-04 2010-04-27 C. R. Bard, Inc. Non-entangling vena cava filter
GB0419954D0 (en) * 2004-09-08 2004-10-13 Advotek Medical Devices Ltd System for directing therapy
GB2418362C (en) * 2004-09-22 2010-05-05 Veryan Medical Ltd Stent
US8808354B2 (en) 2004-09-22 2014-08-19 Veryan Medical Limited Helical stent
US7794473B2 (en) 2004-11-12 2010-09-14 C.R. Bard, Inc. Filter delivery system
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US8267954B2 (en) 2005-02-04 2012-09-18 C. R. Bard, Inc. Vascular filter with sensing capability
EP1879520B1 (en) 2005-05-09 2013-03-13 Angiomed GmbH & Co. Medizintechnik KG Implant delivery device
US7967838B2 (en) 2005-05-12 2011-06-28 C. R. Bard, Inc. Removable embolus blood clot filter
EP1912696A1 (en) 2005-08-09 2008-04-23 C.R.Bard, Inc. Embolus blood clot filter and delivery system
US7918870B2 (en) 2005-09-12 2011-04-05 Bridgepoint Medical, Inc. Endovascular devices and methods
WO2007033052A2 (en) 2005-09-12 2007-03-22 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US11020141B2 (en) 2005-09-12 2021-06-01 Bridgepoint Medical, Inc. Endovascular devices and methods
US8025655B2 (en) 2005-09-12 2011-09-27 Bridgepoint Medical, Inc. Endovascular devices and methods
US8083727B2 (en) 2005-09-12 2011-12-27 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
WO2007053791A1 (en) * 2005-11-07 2007-05-10 Med Institute, Inc. Stent with orientation-dependent properties
CA2940038C (en) 2005-11-18 2018-08-28 C.R. Bard, Inc. Vena cava filter with filament
WO2007133366A2 (en) 2006-05-02 2007-11-22 C. R. Bard, Inc. Vena cava filter formed from a sheet
US9326842B2 (en) 2006-06-05 2016-05-03 C. R . Bard, Inc. Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access
US8414637B2 (en) 2006-09-08 2013-04-09 Boston Scientific Scimed, Inc. Stent
US9060802B2 (en) 2006-11-21 2015-06-23 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US10888354B2 (en) 2006-11-21 2021-01-12 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
US11298511B2 (en) 2006-11-21 2022-04-12 Bridgepoint Medical, Inc. Endovascular devices and methods for exploiting intramural space
JP5564416B2 (en) * 2007-03-29 2014-07-30 ボストン サイエンティフィック リミテッド Lumen reentry device
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
EP1982658A1 (en) * 2007-04-16 2008-10-22 Corlife GbR Vessel connector and kit with applicator for surgery
US7810223B2 (en) 2007-05-16 2010-10-12 Boston Scientific Scimed, Inc. Method of attaching radiopaque markers to intraluminal medical devices, and devices formed using the same
JP5453586B2 (en) 2007-10-22 2014-03-26 ブリッジポイント、メディカル、インコーポレイテッド Device and method for traversing a chronic total occlusion
US8728141B2 (en) * 2007-12-11 2014-05-20 Cornell University Method and apparatus for sealing an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while maintaining substantially normal flow through the body lumen
WO2009100129A2 (en) 2008-02-05 2009-08-13 Chad John Kugler Crossing occlusions in blood vessels
US8337425B2 (en) 2008-02-05 2012-12-25 Bridgepoint Medical, Inc. Endovascular device with a tissue piercing distal probe and associated methods
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
US20090254105A1 (en) * 2008-04-04 2009-10-08 Medtronic Vascular, Inc. Anastomotic connectors
US20090259290A1 (en) * 2008-04-14 2009-10-15 Medtronic Vascular, Inc. Fenestration Segment Stent-Graft and Fenestration Method
US8172863B2 (en) 2008-04-28 2012-05-08 Bridgepoint Medical, Inc. Methods and apparatus for crossing occlusions in blood vessels
AU2009269146B2 (en) 2008-06-30 2013-05-16 Bolton Medical, Inc. Abdominal aortic aneurysms: systems and methods of use
CA2750222C (en) 2009-01-22 2018-02-27 Cornell University Method and apparatus for restricting flow through the wall of a lumen
US20100191168A1 (en) 2009-01-29 2010-07-29 Trustees Of Tufts College Endovascular cerebrospinal fluid shunt
BRPI1012599A2 (en) 2009-03-13 2016-03-22 Bolton Medical Inc system and method for placing an endoluminal prosthesis in a surgical site
MX2012001288A (en) 2009-07-29 2012-06-19 Bard Inc C R Tubular filter.
WO2011025855A2 (en) 2009-08-28 2011-03-03 Si Therapies Ltd. Inverted balloon neck on catheter
CA2799459A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
EP2588042A4 (en) 2010-06-29 2015-03-18 Artventive Medical Group Inc Reducing flow through a tubular structure
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
US9566149B2 (en) 2010-11-16 2017-02-14 W. L. Gore & Associates, Inc. Devices and methods for in situ fenestration of a stent-graft at the site of a branch vessel
US9675487B2 (en) 2010-11-17 2017-06-13 Cook Medical Technologies Llc Prosthesis deployment system for vascular repair
US8657866B2 (en) 2010-12-22 2014-02-25 Cook Medical Technologies Llc Emergency vascular repair prosthesis deployment system
US9526638B2 (en) 2011-02-03 2016-12-27 Endospan Ltd. Implantable medical devices constructed of shape memory material
CN103501735B (en) 2011-03-08 2016-04-06 W.L.戈尔及同仁股份有限公司 For ostomy medical treatment device
WO2012135859A2 (en) 2011-04-01 2012-10-04 Cornell University Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen
US9011514B2 (en) 2011-08-22 2015-04-21 Cook Medical Technologies Llc Emergency vessel repair prosthesis deployment system
WO2013055703A1 (en) 2011-10-07 2013-04-18 Cornell University Method and apparatus for restricting flow through an opening in a body lumen while maintaining normal flow
WO2013084235A2 (en) 2011-12-04 2013-06-13 Endospan Ltd. Branched stent-graft system
US9056171B2 (en) * 2012-02-24 2015-06-16 Medtronic Vascular, Inc. Arteriovenous shunt having eccentric anchor stent
ES2618221T3 (en) 2012-04-12 2017-06-21 Bolton Medical Inc. Vascular prosthesis administration device and method of use
US9993360B2 (en) 2013-01-08 2018-06-12 Endospan Ltd. Minimization of stent-graft migration during implantation
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
US8984733B2 (en) 2013-02-05 2015-03-24 Artventive Medical Group, Inc. Bodily lumen occlusion
AU2014226234B2 (en) 2013-03-08 2017-12-07 Limflow Gmbh Methods and systems for providing or maintaining fluid flow through body passages
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US9439751B2 (en) 2013-03-15 2016-09-13 Bolton Medical, Inc. Hemostasis valve and delivery systems
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9308356B2 (en) 2013-07-29 2016-04-12 Invatec S.P.A. Occlusion bypassing apparatuses and methods for bypassing an occlusion in a blood vessel
US9301777B2 (en) 2013-07-29 2016-04-05 Invatec S.P.A. Occlusion bypassing apparatuses and methods for bypassing an occlusion in a blood vessel
CA2919981C (en) * 2013-07-31 2022-02-15 Cvdevices, Llc Unitary body systems and devices and methods to use the same for retroperfusion
US9364642B2 (en) 2013-08-14 2016-06-14 Invatec S.P.A. Balloon catheter systems and methods for bypassing an occlusion in a blood vessel
US9320874B2 (en) 2013-08-15 2016-04-26 Invatec S.P.A. Catheter systems with a blocking mechanism and methods for bypassing an occlusion in a blood vessel
US9867694B2 (en) 2013-08-30 2018-01-16 Jenavalve Technology Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking
EP3998100A1 (en) 2014-01-15 2022-05-18 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt system
US9737696B2 (en) 2014-01-15 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
US9446222B2 (en) 2014-03-05 2016-09-20 Invatec S.P.A. Catheter assemblies and methods for stabilizing a catheter assembly within a subintimal space
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
US20150313595A1 (en) 2014-05-02 2015-11-05 W. L. Gore & Associates, Inc. Anastomosis Devices
US11712230B2 (en) 2014-05-02 2023-08-01 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US11439396B2 (en) 2014-05-02 2022-09-13 W. L. Gore & Associates, Inc. Occluder and anastomosis devices
US9545263B2 (en) 2014-06-19 2017-01-17 Limflow Gmbh Devices and methods for treating lower extremity vasculature
US10456557B2 (en) 2014-08-14 2019-10-29 Invatec S.P.A. Occlusion bypassing apparatus with varying flexibility and methods for bypassing an occlusion in a blood vessel
JP6586172B2 (en) 2014-10-31 2019-10-02 セレバスク, エルエルシーCereVasc, LLC Method and system for treating hydrocephalus
BR112017012425A2 (en) 2014-12-18 2018-01-02 Endospan Ltd endovascular stent graft with fatigue resistant lateral tube
CN107205811B (en) * 2015-01-12 2019-06-25 恩都思潘有限公司 From curved stent graft
EP3288495B1 (en) 2015-05-01 2019-09-25 JenaValve Technology, Inc. Device with reduced pacemaker rate in heart valve replacement
US10172632B2 (en) 2015-09-22 2019-01-08 Medtronic Vascular, Inc. Occlusion bypassing apparatus with a re-entry needle and a stabilization tube
US10327791B2 (en) 2015-10-07 2019-06-25 Medtronic Vascular, Inc. Occlusion bypassing apparatus with a re-entry needle and a distal stabilization balloon
EP3362005B1 (en) * 2015-10-15 2020-12-16 Medical Development Technologies S.A. Improved implant device
CN108136164B (en) 2015-10-30 2020-12-08 西瑞维斯克公司 Systems and methods for treating hydrocephalus
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
FR3060967A1 (en) * 2016-12-22 2018-06-29 Ass Marie Lannelongue FLUIDIC OCCLUSION DEVICE BY CLOSING
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
EP4299086A2 (en) 2017-04-10 2024-01-03 LimFlow GmbH Devices for treating lower extremity vasculature
US11724075B2 (en) 2017-04-18 2023-08-15 W. L. Gore & Associates, Inc. Deployment constraining sheath that enables staged deployment by device section
WO2018218017A1 (en) * 2017-05-25 2018-11-29 Boston Scientific Scimed, Inc. Devices and methods for multi-lumen access and drainage
EP3762083A1 (en) 2018-03-08 2021-01-13 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
WO2020076833A1 (en) 2018-10-09 2020-04-16 Limflow Gmbh Devices and methods for catheter alignment
JP2023500067A (en) 2019-11-01 2023-01-04 リムフロウ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Devices and methods for increasing blood perfusion to distal limbs
JP2023548982A (en) 2020-11-09 2023-11-21 ヴェノヴァ メディカル、インコーポレイテッド Endovascular implants, devices, and accurate placement methods

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042021A (en) 1958-11-25 1962-07-03 Read Thane Bypass type insert plug for body passageway
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
DE9116881U1 (en) 1990-10-09 1994-07-07 Cook Inc Percutaneous stent
CA2060067A1 (en) 1991-01-28 1992-07-29 Lilip Lau Stent delivery system
US5314472A (en) 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
US5527354A (en) 1991-06-28 1996-06-18 Cook Incorporated Stent formed of half-round wire
US5354309A (en) 1991-10-11 1994-10-11 Angiomed Ag Apparatus for widening a stenosis in a body cavity
CA2380683C (en) 1991-10-28 2006-08-08 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
FR2683449A1 (en) 1991-11-08 1993-05-14 Cardon Alain ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION.
US5507767A (en) 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5683448A (en) 1992-02-21 1997-11-04 Boston Scientific Technology, Inc. Intraluminal stent and graft
FR2688401B1 (en) 1992-03-12 1998-02-27 Thierry Richard EXPANDABLE STENT FOR HUMAN OR ANIMAL TUBULAR MEMBER, AND IMPLEMENTATION TOOL.
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
EP0607468B1 (en) 1992-12-16 1994-09-21 Schneider (Europe) Ag Stent placement instrument
DE4303181A1 (en) 1993-02-04 1994-08-11 Angiomed Ag Implantable catheter
WO1994023786A1 (en) 1993-04-13 1994-10-27 Boston Scientific Corporation Prosthesis delivery system
EP0695152A1 (en) 1993-04-23 1996-02-07 Schneider (Usa) Inc. Covered stent and stent delivery device
DE4334140C2 (en) 1993-10-07 1996-04-18 Angiomed Ag Stent and device with stent
US5571135A (en) 1993-10-22 1996-11-05 Scimed Life Systems Inc. Stent delivery apparatus and method
WO1995013033A1 (en) * 1993-11-08 1995-05-18 Lazarus Harrison M Intraluminal vascular graft and method
US5443497A (en) 1993-11-22 1995-08-22 The Johns Hopkins University Percutaneous prosthetic by-pass graft and method of use
JP2703510B2 (en) 1993-12-28 1998-01-26 アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド Expandable stent and method of manufacturing the same
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US5683411A (en) 1994-04-06 1997-11-04 William Cook Europe A/S Medical article for implantation into the vascular system of a patient
DE69510986T2 (en) 1994-04-25 1999-12-02 Advanced Cardiovascular System Radiation-opaque stent markings
US5554181A (en) 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
US5456694A (en) 1994-05-13 1995-10-10 Stentco, Inc. Device for delivering and deploying intraluminal devices
DE4418336A1 (en) 1994-05-26 1995-11-30 Angiomed Ag Stent for widening and holding open receptacles
FR2722678B1 (en) * 1994-07-25 1996-12-27 Braun Celsa Sa B PLUG-IN MEDICAL PROSTHESIS FOR USE IN THE TREATMENT OF ANEVRISMS, DEVICE COMPRISING SUCH A PROSTHESIS
US5609605A (en) * 1994-08-25 1997-03-11 Ethicon, Inc. Combination arterial stent
US5702419A (en) 1994-09-21 1997-12-30 Wake Forest University Expandable, intraluminal stents
US5545210A (en) 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5836965A (en) 1994-10-19 1998-11-17 Jendersee; Brad Stent delivery and deployment method
NL9500284A (en) 1994-10-20 1996-06-03 Cordis Europ Catheter for stent implantation.
CA2201128C (en) 1994-10-27 2000-10-24 Jeffrey A. Helgerson Stent delivery device
CA2134997C (en) 1994-11-03 2009-06-02 Ian M. Penn Stent
CA2301351C (en) 1994-11-28 2002-01-22 Advanced Cardiovascular Systems, Inc. Method and apparatus for direct laser cutting of metal stents
DE4446036C2 (en) 1994-12-23 1999-06-02 Ruesch Willy Ag Placeholder for placement in a body tube
US5591226A (en) 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
US5556414A (en) * 1995-03-08 1996-09-17 Wayne State University Composite intraluminal graft
US5571168A (en) 1995-04-05 1996-11-05 Scimed Lifesystems Inc Pull back stent delivery system
BE1009278A3 (en) 1995-04-12 1997-01-07 Corvita Europ Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as.
US5746766A (en) 1995-05-09 1998-05-05 Edoga; John K. Surgical stent
US5628786A (en) 1995-05-12 1997-05-13 Impra, Inc. Radially expandable vascular graft with resistance to longitudinal compression and method of making same
EP0831753B1 (en) * 1995-06-01 2005-12-28 Meadox Medicals, Inc. Implantable intraluminal prosthesis
US5593442A (en) * 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
US5728131A (en) 1995-06-12 1998-03-17 Endotex Interventional Systems, Inc. Coupling device and method of use
CA2226635C (en) 1995-07-07 2003-12-23 W.L. Gore & Associates, Inc. Interior liner for tubes, pipes and blood conduits
CN1208101C (en) 1995-07-25 2005-06-29 梅德斯坦特有限公司 Expansible stent
US5702418A (en) 1995-09-12 1997-12-30 Boston Scientific Corporation Stent delivery system
DE69633411T2 (en) * 1995-10-13 2005-10-20 Transvascular, Inc., Menlo Park METHOD AND DEVICE FOR PREVENTING ARTERIAL ATTRACTIONS AND / OR FOR CARRYING OUT OTHER TRANSVASCULAR INTERVENTIONS
EP0955933B1 (en) 1995-10-13 2009-08-26 Medtronic Vascular, Inc. A device for interstitial transvascular intervention
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US5591195A (en) 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
AU733341B2 (en) 1996-02-02 2001-05-10 Transvascular, Inc. A device, system and method for interstitial transvascular intervention
WO1997027898A1 (en) * 1996-02-02 1997-08-07 Transvascular, Inc. Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
US5695516A (en) 1996-02-21 1997-12-09 Iso Stent, Inc. Longitudinally elongating balloon expandable stent
US5868780A (en) 1996-03-22 1999-02-09 Lashinski; Robert D. Stents for supporting lumens in living tissue
US5752961A (en) 1996-03-25 1998-05-19 The University Of Kentucky Research Foundation Angled snare assembly
US5725548A (en) 1996-04-08 1998-03-10 Iowa India Investments Company Limited Self-locking stent and method for its production
US5713949A (en) 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
FR2747912B1 (en) * 1996-04-24 1999-01-22 Legona Anstalt INTRACORPOREAL STENT TO BE PLACED IN A BODY CHANNEL
US5755773A (en) 1996-06-04 1998-05-26 Medtronic, Inc. Endoluminal prosthetic bifurcation shunt
US5697971A (en) 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5797920A (en) 1996-06-14 1998-08-25 Beth Israel Deaconess Medical Center Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US5676670A (en) 1996-06-14 1997-10-14 Beth Israel Deaconess Medical Center Catheter apparatus and method for creating a vascular bypass in-vivo
JP2002515785A (en) 1996-06-25 2002-05-28 メドトロニック,インコーポレイテッド A group of endoluminal prostheses having certain characteristics and a method of manufacturing the same
US5928279A (en) 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
US5776140A (en) 1996-07-16 1998-07-07 Cordis Corporation Stent delivery system
US5800517A (en) 1996-08-19 1998-09-01 Scimed Life Systems, Inc. Stent delivery system with storage sleeve
US5776183A (en) 1996-08-23 1998-07-07 Kanesaka; Nozomu Expandable stent
EP0932377B1 (en) 1996-08-23 2006-06-28 Boston Scientific Scimed, Inc. Stent delivery system having stent securement apparatus
US5980530A (en) 1996-08-23 1999-11-09 Scimed Life Systems Inc Stent delivery system
DK176341B1 (en) 1996-09-06 2007-08-27 Cook William Europ Aggregate for transluminal insertion of a tubular stent and an endovascular graft device
US5772669A (en) 1996-09-27 1998-06-30 Scimed Life Systems, Inc. Stent deployment catheter with retractable sheath
US5868781A (en) 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
WO1998019631A1 (en) 1996-11-07 1998-05-14 Vascular Science Inc. Artificial medical graft methods and apparatus
EP0951251B1 (en) 1996-11-07 2005-03-16 St. Jude Medical ATG, Inc. Medical grafting connectors
US5976178A (en) 1996-11-07 1999-11-02 Vascular Science Inc. Medical grafting methods
WO1998019732A1 (en) 1996-11-07 1998-05-14 Vascular Science Inc. Steerable instrument for use in medical procedures
EP0951252A2 (en) 1996-11-07 1999-10-27 Vascular Science Inc. Medical grafting methods and apparatus
WO1998019608A1 (en) 1996-11-07 1998-05-14 Vascular Science Inc. Medical instrument with extendable snare
AU5197098A (en) 1996-11-07 1998-05-29 Vascular Science Inc. Artificial tubular body organ grafts
AU5162598A (en) 1996-11-07 1998-05-29 Vascular Science Inc. Tubular medical graft connectors
US5779731A (en) 1996-12-20 1998-07-14 Cordis Corporation Balloon catheter having dual markers and method
US5733330A (en) 1997-01-13 1998-03-31 Advanced Cardiovascular Systems, Inc. Balloon-expandable, crush-resistant locking stent
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
DE29702671U1 (en) 1997-02-17 1997-04-10 Jomed Implantate Gmbh Stent
US6155264A (en) 1997-03-06 2000-12-05 Scimed Life Systems, Inc. Percutaneous bypass by tunneling through vessel wall
US6035856A (en) 1997-03-06 2000-03-14 Scimed Life Systems Percutaneous bypass with branching vessel
US6026814A (en) 1997-03-06 2000-02-22 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
US5810872A (en) 1997-03-14 1998-09-22 Kanesaka; Nozomu Flexible stent
US5817126A (en) 1997-03-17 1998-10-06 Surface Genesis, Inc. Compound stent
US5792144A (en) 1997-03-31 1998-08-11 Cathco, Inc. Stent delivery catheter system
US5868783A (en) * 1997-04-16 1999-02-09 Numed, Inc. Intravascular stent with limited axial shrinkage
US6033433A (en) 1997-04-25 2000-03-07 Scimed Life Systems, Inc. Stent configurations including spirals
US5741327A (en) 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
US5836966A (en) 1997-05-22 1998-11-17 Scimed Life Systems, Inc. Variable expansion force stent

Also Published As

Publication number Publication date
EP1037571A1 (en) 2000-09-27
AU1392899A (en) 1999-06-07
EP1037571A4 (en) 2003-05-28
JP2001522692A (en) 2001-11-20
US6432127B1 (en) 2002-08-13
IL135918A0 (en) 2001-05-20
WO1999025273A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
US6432127B1 (en) Devices for forming and/or maintaining connections between adjacent anatomical conduits
US20020029079A1 (en) Devices for forming and/or maintaining connections between adjacent anatomical conduits
US20040088042A1 (en) Devices for forming and/or maintaining connections between adjacent anatomical conduits
USRE45865E1 (en) Prosthetic valve for transluminal delivery
US7159592B1 (en) Methods and apparatus for transmyocardial direct coronary revascularization
KR101652568B1 (en) Vascular stenting for aneurysms
ES2392621T3 (en) Device for deploying cannulas
US6602280B2 (en) Delivery system and method for expandable intracorporeal device
EP1836995A1 (en) Prothesis with adjustable for side branch access
US20140121765A1 (en) Methods For Transluminal Delivery Of Prosthetic Valves
JP2002200174A (en) Improved delivery apparatus for self-expanding retractable stent
AU1847397A (en) Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
KR20120044928A (en) Vascular stenting for aneurysms
JP2002191701A (en) Stent implant having improved attaching means in blood vessel in body
JP2004509653A (en) Stent for easy drainage
MXPA00004542A (en) Devices for forming and/or maintaining connections between adjacent anatomical conduits
AU4237102A (en) Method and apparatus for transmyocardial direct coronary revascularization

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued